Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga • 07/21/26
Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 07/16/26
Danaher (DHR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/14/26
Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment24/7 Wall Street • 07/10/26
Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?Zacks Investment Research • 07/08/26
Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central AfricaPRNewsWire • 06/29/26
Danaher (DHR) Crossed Above the 20-Day Moving Average: What That Means for InvestorsZacks Investment Research • 06/25/26
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?The Motley Fool • 06/24/26
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?Zacks Investment Research • 06/11/26